Form 8-K - Current report:
SEC Accession No. 0001213900-19-022028
Filing Date
2019-11-05
Accepted
2019-11-05 11:42:02
Documents
6
Period of Report
2019-11-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k110519_citiuspharma.htm 8-K 20660
2 CITIUS CORPORATE UPDATE, NOVEMBER 2019 f8k110519ex99-1_citius.htm EX-99.1 36415
3 GRAPHIC image_001.jpg GRAPHIC 7069
4 GRAPHIC image_002.jpg GRAPHIC 17815
5 GRAPHIC image_003.jpg GRAPHIC 12946
6 GRAPHIC image_004.jpg GRAPHIC 7736
  Complete submission text file 0001213900-19-022028.txt   121684
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 191192296
SIC: 2834 Pharmaceutical Preparations